Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2005 033 427.0 |
96 | EP file number | EAKZ | 05 79 9991.4 |
86 | WO file number | WAKZ | PCT/IB2005/002941 |
97 | EP publication number | EPN | 1799685 |
87 | WO publication number | WPN | 2006033007 |
54 | Designation/title | TI | POLYMORPHE FORMEN DES PHOSPHATSALZES VON 8-FLUOR-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ON |
51 | IPC main class | ICM (ICMV) | C07D 487/06 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/55 (2006.01), A61P 35/00 (2006.01), A61P 25/00 (2006.01) |
22 | DE application date | DAT | Sep 12, 2005 |
96 | EP application date | EAT | Sep 12, 2005 |
86 | WO application date | WAT | Sep 12, 2005 |
43 | Date of first publication | OT | Mar 30, 2006 |
| Date of publication of grant | PET | Mar 28, 2012 |
71/73 | Applicant/owner | INH | Pfizer Inc., 10017 New York, N.Y., US; Cancer Research Technology Ltd., London, GB |
72 | Inventor | IN | NAYYAR, Naresh,Agouron Pharmaceuticals, Inc., San Diego, CA 92121, US; CHU, Jan-Jon,Agouron Pharmaceuticals, Inc., San Diego, CA92121, US; WU, Zhen-Ping,Agouron Pharmaceuticals, Inc., San Diego, CA 92121, US; BORER Bennett C.,Agouron Pharmaceuticals, Inc., San Diego, CA 92121, US; SRIRANGAM, A.N.,Agouron Pharmaceuticals, Inc., San Diego, CA 92121, US; LI, Yi,Agouron Pharmaceuticals, Inc., San Diego, CA 92121, US; LIU, Jia,Agouron Pharmaceuticals, Inc., San Diego, CA 92121, US; MITCHELL, Mark B.,Agouron Pharmaceuticals, Inc., San Diego, CA 92121, US; GUO, MingAgouron Pharmaceuticals, Inc.A Pfizer Company, San Diego, CA 92121, US |
74 | Representative | VTR | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE |
| Address for service | | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 679296 P May 9, 2005
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 612459 P Sep 22, 2004
|
| Due date | FT FG | Sep 30, 2024 Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001799685 Searchable text:
EP000001799685 Original document:
EP000001799685B1 Searchable text:
EP000001799685B1 Original document:
WO002006033007 Searchable text:
WO002006033007 |
43 | Date of first publication | EVT | Mar 30, 2006 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Dec 14, 2024 (Show all update days)(Hide all update days)- Dec 14, 2024
- St.36: changed (technical change)
- Jun 8, 2024; Aug 2, 2023; Jun 24, 2022; Jun 8, 2022; Aug 7, 2021; Sep 10, 2020; Sep 7, 2019; Oct 10, 2018; Sep 5, 2018; Sep 20, 2017; Sep 24, 2016; Sep 22, 2015; Aug 25, 2015; Sep 24, 2014; Oct 8, 2013; Sep 19, 2013; Apr 25, 2013; Jan 30, 2013; Oct 9, 2012; Sep 14, 2012; May 24, 2012; Apr 4, 2012; Mar 29, 2012; Feb 15, 2012; Sep 15, 2011; May 31, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|